Corrigendum to ‘The CAP-CR study: Direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine’ [European Journal of Cancer 44 (2008) 2615–2622]

Autor: Lopatriello, S., Amoroso, D., Donati, S., Alabiso, O., Forti, L., Fornasiero, A., Smergo, A., Lalli, A., Iacono, C., Lucenti, A., D’Alonzo, L., Negrini, C.
Zdroj: In European Journal of Cancer 2009 45(12):2228-2228
Databáze: ScienceDirect